J&J Unit Challenges US Gov't Cancer Drug Patent In UK
Johnson & Johnson's research unit has asked a London judge to revoke a patent for a blood cancer treatment owned by the U.S. government, as the pharmaceutical giant prepares to launch...To view the full article, register now.
Already a subscriber? Click here to view full article